We constructed a TMA (three cores/patient) using samples from 192 patients with pancreatic cancer (Table 1) and performed IHC staining, for CD56 and NKp46 (Supplementary Fig. S2), NK cell surface markers (28). This evidence concerns the gene NCAM1 and pancreatic neoplasm.